|
GB9127062D0
(en)
*
|
1991-12-20 |
1992-02-19 |
Unilever Plc |
Lip treatment composition
|
|
WO1994013257A1
(en)
*
|
1992-12-16 |
1994-06-23 |
Creative Products Resource Associates, Ltd. |
Occlusive/semi-occlusive lotion for treatment of a skin disease or disorder
|
|
JP3566739B2
(ja)
*
|
1993-09-30 |
2004-09-15 |
三省製薬株式会社 |
皮膚外用剤の安定化方法
|
|
US7135584B2
(en)
*
|
1995-08-07 |
2006-11-14 |
Wake Forest University |
Lipid analogs for treating viral infections
|
|
EP0781138B1
(en)
|
1994-08-29 |
2008-05-21 |
Wake Forest University |
Lipid analogs for treating viral infections
|
|
US5614489A
(en)
*
|
1995-05-25 |
1997-03-25 |
Mohammadi; Fatemeh |
Method and composition for treating the skin
|
|
FR2736827B1
(fr)
*
|
1995-07-21 |
1997-09-19 |
Boucher Christine Bernard |
Huile cosmetique extraite des plantes du genre calophyllum
|
|
FR2737118B1
(fr)
*
|
1995-07-28 |
1997-09-05 |
Oreal |
Composition dermatologique ou pharmaceutique, procede de preparation et utilisation
|
|
US5932553A
(en)
*
|
1996-07-18 |
1999-08-03 |
The Regents Of The University Of California |
Illudin analogs useful as antitumor agents
|
|
US5723632A
(en)
|
1996-08-08 |
1998-03-03 |
Mgi Pharma, Inc. |
Total synthesis of antitumor acylfulvenes
|
|
DE19720083A1
(de)
*
|
1997-05-14 |
1998-11-19 |
Silvia Zender |
Arzneimittel
|
|
WO1999012901A1
(en)
*
|
1997-09-08 |
1999-03-18 |
Georgetown University |
Substituted 2-pyrrolidinone activators of pkc
|
|
US6486214B1
(en)
|
1997-09-10 |
2002-11-26 |
Rutgers, The State University Of New Jersey |
Polyanhydride linkers for production of drug polymers and drug polymer compositions produced thereby
|
|
WO1999033838A1
(en)
*
|
1997-12-29 |
1999-07-08 |
Research Corporation Technologies, Inc. |
2-β-SUBSTITUTED-6-ALKYLIDENE PENICILLANIC ACID DERIVATIVES AS β-LACTAMASE INHIBITORS
|
|
US6051603A
(en)
|
1998-01-20 |
2000-04-18 |
Wayne Hughes Institute |
Vanadium (IV) metallocene complexes having sperm motility inhibiting activity
|
|
US6432941B1
(en)
*
|
1998-01-20 |
2002-08-13 |
Parker Hughes Institute |
Vanadium compounds for treating cancer
|
|
US6245808B1
(en)
|
1998-11-05 |
2001-06-12 |
Parker Hughes Institute |
Oxy-vanadium (IV) complexes having spermicidal activity
|
|
US6025328A
(en)
|
1998-02-20 |
2000-02-15 |
The Regents Of The University Of California |
Antitumor agents
|
|
US7141603B2
(en)
*
|
1999-02-19 |
2006-11-28 |
The Regents Of The University California |
Antitumor agents
|
|
DE19825856A1
(de)
*
|
1998-06-10 |
1999-12-16 |
Labtec Gmbh |
Topische Arzneimittelzubereitung
|
|
US6355678B1
(en)
|
1998-06-29 |
2002-03-12 |
Parker Hughes Institute |
Inhibitors of the EGF-receptor tyrosine kinase and methods for their use
|
|
US6800649B1
(en)
|
1998-06-30 |
2004-10-05 |
Parker Hughes Institute |
Method for inhibiting c-jun expression using JAK-3 inhibitors
|
|
US8263580B2
(en)
*
|
1998-09-11 |
2012-09-11 |
Stiefel Research Australia Pty Ltd |
Vitamin formulation
|
|
AUPP583198A0
(en)
*
|
1998-09-11 |
1998-10-01 |
Soltec Research Pty Ltd |
Mousse composition
|
|
JP3211027B2
(ja)
*
|
1998-11-13 |
2001-09-25 |
丸石製薬株式会社 |
カプサイシン含有外用剤
|
|
US6080747A
(en)
*
|
1999-03-05 |
2000-06-27 |
Hughes Institute |
JAK-3 inhibitors for treating allergic disorders
|
|
JP2002539130A
(ja)
|
1999-03-09 |
2002-11-19 |
ファルマシア・アンド・アップジョン・カンパニー |
抗ウイルス剤としての４−オキソ−４，７−ジヒドロ−チエノ［２，３−ｂ］ピリジン−５−カルボキサミド
|
|
US6306897B1
(en)
|
1999-03-19 |
2001-10-23 |
Parker Hughes Institute |
Calanolides for inhibiting BTK
|
|
US6258820B1
(en)
*
|
1999-03-19 |
2001-07-10 |
Parker Hughes Institute |
Synthesis and anti-tumor activity of 6,7-dialkoxy-4-phenylamino-quinazolines
|
|
US6407091B1
(en)
*
|
1999-04-15 |
2002-06-18 |
Research Corporation Technologies, Inc. |
β-lactamase inhibiting compounds
|
|
AU779783B2
(en)
*
|
1999-05-17 |
2005-02-10 |
Eisai Inc. |
Improved cellular uptake of bioactive agents
|
|
US6930101B1
(en)
|
1999-05-17 |
2005-08-16 |
The Regents Of The University Of California |
Thiazolopyrimidines useful as TNFα inhibitors
|
|
US6551998B1
(en)
*
|
1999-06-22 |
2003-04-22 |
University Of Louisville Research Foundation, Inc. |
Antimicrobial agents
|
|
US6670341B1
(en)
|
1999-10-28 |
2003-12-30 |
Wake Forest University Health Sciences |
Compositions and methods for double-targeting virus infections and targeting cancer cells
|
|
US7026469B2
(en)
|
2000-10-19 |
2006-04-11 |
Wake Forest University School Of Medicine |
Compositions and methods of double-targeting virus infections and cancer cells
|
|
US6740650B2
(en)
|
1999-10-29 |
2004-05-25 |
Rutgers, The State University Of New Jersey |
Heterocyclic cytotoxic agents
|
|
AU1608801A
(en)
|
1999-11-15 |
2001-05-30 |
Parker Hughes Institute |
Diamino platinum (ii) antitumor complexes
|
|
US6649654B1
(en)
|
1999-11-23 |
2003-11-18 |
The Regents Of The University Of California |
Methods for identifying and using IKK inhibitors
|
|
US6589992B2
(en)
|
1999-11-30 |
2003-07-08 |
Parker Hughes Institute |
Inhibiting collagen-induced platelet aggregation
|
|
US6967023B1
(en)
*
|
2000-01-10 |
2005-11-22 |
Foamix, Ltd. |
Pharmaceutical and cosmetic carrier or composition for topical application
|
|
IL133968A0
(en)
*
|
2000-01-10 |
2001-04-30 |
Thixo Ltd |
Therapeutic oils and edible pastes containing the same
|
|
JP2003531195A
(ja)
|
2000-03-21 |
2003-10-21 |
ファルマシア・アンド・アップジョン・カンパニー |
抗ウイルス剤としての４−ヒドロキシシンノリン−３−カルボキサミド
|
|
CA2399991A1
(en)
|
2000-03-21 |
2001-09-27 |
Pharmacia & Upjohn Company |
4-hydroxy-1,8-naphthyridine-3-carboxamides as antiviral agents
|
|
NZ521522A
(en)
|
2000-03-21 |
2004-08-27 |
Upjohn Co |
4-oxo-1,4-dihydro[1,8]naphthyridine-3-carboxamides useful as antiviral agents
|
|
US8512718B2
(en)
|
2000-07-03 |
2013-08-20 |
Foamix Ltd. |
Pharmaceutical composition for topical application
|
|
US6682892B2
(en)
*
|
2000-07-13 |
2004-01-27 |
Pharmacia & Upjohn Company |
Method for treating herpes viruses
|
|
US6696441B1
(en)
|
2000-08-11 |
2004-02-24 |
The Regents Of The University Of California |
Inhibition of p53-induced stress response
|
|
US6951847B2
(en)
*
|
2000-09-29 |
2005-10-04 |
Regents Of The University Of Minnesota |
Methods of treating fungal infections using lupeol
|
|
AU2001294959A1
(en)
|
2000-09-29 |
2002-04-08 |
Robert M. Carlson |
Triterpenes having antibacterial activity
|
|
AU2001294953A1
(en)
|
2000-09-29 |
2002-04-08 |
Regents Of The University Of Minnesota |
Triterpenes having fungicidal activity against yeast
|
|
US7309696B2
(en)
|
2000-10-19 |
2007-12-18 |
Wake Forest University |
Compositions and methods for targeting cancer cells
|
|
US6642221B1
(en)
|
2000-11-15 |
2003-11-04 |
Parker Hughes Institute |
Vanadium compounds as anti-proliferative agents
|
|
US6958359B1
(en)
|
2000-11-15 |
2005-10-25 |
Parker Hughes Institute |
Vanadium compounds as anti-angiogenic agents
|
|
US6878388B1
(en)
|
2000-11-15 |
2005-04-12 |
Parker Hughes Institute |
Vanadium compounds for treating proliferative cell disorders
|
|
AU2002249885A1
(en)
|
2000-11-17 |
2002-08-12 |
Adolor Corporation |
Delta agonist analgesics
|
|
WO2002060936A2
(en)
*
|
2001-01-31 |
2002-08-08 |
University Of Iowa Research Foundation |
Vaccine and compositions for the prevention and treatment of neisserial infections
|
|
US7261901B2
(en)
*
|
2001-01-31 |
2007-08-28 |
University Of Iowa Research Foundation |
Vaccine and compositions for the prevention and treatment of neisserial infections
|
|
US7232829B2
(en)
*
|
2001-04-06 |
2007-06-19 |
Regents Of The University Of Minnesota |
Therapeutic compounds and methods
|
|
CN1486289A
(zh)
*
|
2001-05-29 |
2004-03-31 |
皇家菲利浦电子有限公司 |
金属-陶瓷的结合
|
|
US20030232794A1
(en)
*
|
2001-06-26 |
2003-12-18 |
Cottam Howard B. |
Use of STAT-6 inhibitors as therapeutic agents
|
|
US7601846B2
(en)
*
|
2001-06-26 |
2009-10-13 |
The Regents Of The University Of California |
Compounds having activity as inhibitors of apoptosis
|
|
WO2003020732A2
(en)
*
|
2001-07-24 |
2003-03-13 |
Alamx, L.L.C. |
7-alkylidene-3-substituted-3-cephem-4-carboxylates as beta-lactamase inhibitors.
|
|
US20030171377A1
(en)
*
|
2001-08-29 |
2003-09-11 |
Bigge Christopher Franklin |
Antidiabetic agents
|
|
EP1423976A1
(en)
*
|
2001-08-31 |
2004-06-02 |
Thomson Licensing S.A. |
Sequence counter for an audio visual stream
|
|
US20040157280A1
(en)
*
|
2001-09-17 |
2004-08-12 |
Paul Wentworth |
Antibody mediated ozone generation
|
|
US20040116350A1
(en)
*
|
2001-09-17 |
2004-06-17 |
Paul Wentworth Jr |
Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies
|
|
US20050129680A1
(en)
*
|
2001-09-17 |
2005-06-16 |
Paul Wentworth |
Antimicrobial activity of antibodies
|
|
EP1434782A2
(en)
*
|
2001-10-01 |
2004-07-07 |
University of Virginia Patent Foundation |
2-propynyl adenosine analogs having a2a agonist activity and compositions thereof
|
|
AU2002334969A1
(en)
*
|
2001-10-09 |
2003-04-22 |
Sylvie Barchechath |
Use of stat-6 inhibitors as therapeutic agents
|
|
DE60235287D1
(de)
|
2001-11-14 |
2010-03-25 |
Univ Rutgers |
Löslich gemachte topoisomerase-gifte
|
|
JP2005510571A
(ja)
|
2001-11-23 |
2005-04-21 |
ラトガーズ， ザ ステート ユニバーシティー |
ポリ無水物の改善された合成
|
|
US7030141B2
(en)
*
|
2001-11-29 |
2006-04-18 |
Christopher Franklin Bigge |
Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade
|
|
JP2005530685A
(ja)
*
|
2002-01-25 |
2005-10-13 |
リージェンツ オブ ザ ユニバーシティ オブ ミネソタ |
選択的鎮痛剤
|
|
AU2003224874A1
(en)
*
|
2002-04-04 |
2003-10-27 |
Alamx, L.L.C. |
INHIBITORS OF SERINE AND METALLO-ss-LACTAMASES
|
|
AUPS158502A0
(en)
*
|
2002-04-08 |
2002-05-16 |
Dermcare-Vet Pty Ltd |
Allergic dermatitis composition and method of treatment
|
|
AU2003234716A1
(en)
*
|
2002-04-10 |
2003-10-27 |
Joel M. Linden |
Use of a2a adenosine receptor agonists for the treatment of inflammatory diseases
|
|
US20040156799A1
(en)
*
|
2002-06-04 |
2004-08-12 |
Zigang Dong |
Cancer treatment method and compositions
|
|
UA79293C2
(en)
*
|
2002-07-03 |
2007-06-11 |
Univ Wayne State |
4-(7'-halo-2-quino (xa-) linyloxy)phenoxy propionic acid derivatives as antineoplastic agents
|
|
NZ538405A
(en)
*
|
2002-08-01 |
2007-12-21 |
Aesgen Inc |
Improved treatment of cancer with glutamine and carbohydrate
|
|
US6989387B2
(en)
*
|
2002-08-09 |
2006-01-24 |
Rutgers, The State University Of New Jersey |
Nitro and amino substituted topoisomerase agents
|
|
US7438918B2
(en)
*
|
2002-08-30 |
2008-10-21 |
University Of Iowa Research Foundation |
Lipid A deficient mutants of Neisseria meningitidis
|
|
CA2497003A1
(en)
*
|
2002-09-11 |
2004-03-25 |
Warner-Lambert Company Llc |
Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
|
|
EP2447278B1
(en)
|
2002-10-10 |
2015-04-08 |
Cornell Research Foundation, Inc. |
Novel immunogenic proteins of Leptospira
|
|
EP1552025A4
(en)
*
|
2002-10-18 |
2006-12-13 |
Cylene Pharmaceuticals Inc |
METHOD FOR IDENTIFYING ANTIVIRAL MOLECULES DETECTED BY A QUADRUPLEX STRUCTURE
|
|
IL152486A0
(en)
*
|
2002-10-25 |
2003-05-29 |
Meir Eini |
Alcohol-free cosmetic and pharmaceutical foam carrier
|
|
US8119109B2
(en)
*
|
2002-10-25 |
2012-02-21 |
Foamix Ltd. |
Foamable compositions, kits and methods for hyperhidrosis
|
|
US20050205086A1
(en)
*
|
2002-10-25 |
2005-09-22 |
Foamix Ltd. |
Retinoid immunomodulating kit and composition and uses thereof
|
|
US7544674B2
(en)
*
|
2002-10-25 |
2009-06-09 |
Galderma S.A. |
Topical skin care composition
|
|
US8900554B2
(en)
|
2002-10-25 |
2014-12-02 |
Foamix Pharmaceuticals Ltd. |
Foamable composition and uses thereof
|
|
US8486376B2
(en)
*
|
2002-10-25 |
2013-07-16 |
Foamix Ltd. |
Moisturizing foam containing lanolin
|
|
US20080206161A1
(en)
*
|
2002-10-25 |
2008-08-28 |
Dov Tamarkin |
Quiescent foamable compositions, steroids, kits and uses thereof
|
|
ES2532906T5
(es)
|
2002-10-25 |
2022-03-23 |
Foamix Pharmaceuticals Ltd |
Espuma cosmética y farmacéutica
|
|
US9211259B2
(en)
|
2002-11-29 |
2015-12-15 |
Foamix Pharmaceuticals Ltd. |
Antibiotic kit and composition and uses thereof
|
|
US7820145B2
(en)
*
|
2003-08-04 |
2010-10-26 |
Foamix Ltd. |
Oleaginous pharmaceutical and cosmetic foam
|
|
US8119150B2
(en)
|
2002-10-25 |
2012-02-21 |
Foamix Ltd. |
Non-flammable insecticide composition and uses thereof
|
|
US20070292359A1
(en)
*
|
2002-10-25 |
2007-12-20 |
Foamix Ltd. |
Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
|
|
US20050186142A1
(en)
*
|
2002-10-25 |
2005-08-25 |
Foamix Ltd. |
Kit and composition of imidazole with enhanced bioavailability
|
|
US9668972B2
(en)
|
2002-10-25 |
2017-06-06 |
Foamix Pharmaceuticals Ltd. |
Nonsteroidal immunomodulating kit and composition and uses thereof
|
|
US20080317679A1
(en)
*
|
2002-10-25 |
2008-12-25 |
Foamix Ltd. |
Foamable compositions and kits comprising one or more of a channel agent, a cholinergic agent, a nitric oxide donor, and related agents and their uses
|
|
US20070292355A1
(en)
*
|
2002-10-25 |
2007-12-20 |
Foamix Ltd. |
Anti-infection augmentation foamable compositions and kit and uses thereof
|
|
US20050271596A1
(en)
*
|
2002-10-25 |
2005-12-08 |
Foamix Ltd. |
Vasoactive kit and composition and uses thereof
|
|
US20080138296A1
(en)
|
2002-10-25 |
2008-06-12 |
Foamix Ltd. |
Foam prepared from nanoemulsions and uses
|
|
US9265725B2
(en)
|
2002-10-25 |
2016-02-23 |
Foamix Pharmaceuticals Ltd. |
Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
|
|
US7700076B2
(en)
*
|
2002-10-25 |
2010-04-20 |
Foamix, Ltd. |
Penetrating pharmaceutical foam
|
|
US20060193789A1
(en)
*
|
2002-10-25 |
2006-08-31 |
Foamix Ltd. |
Film forming foamable composition
|
|
US10117812B2
(en)
|
2002-10-25 |
2018-11-06 |
Foamix Pharmaceuticals Ltd. |
Foamable composition combining a polar solvent and a hydrophobic carrier
|
|
US7704518B2
(en)
|
2003-08-04 |
2010-04-27 |
Foamix, Ltd. |
Foamable vehicle and pharmaceutical compositions thereof
|
|
US20060018937A1
(en)
*
|
2002-10-25 |
2006-01-26 |
Foamix Ltd. |
Steroid kit and foamable composition and uses thereof
|
|
CA2505316C
(en)
|
2002-11-08 |
2014-08-05 |
Ablynx N.V. |
Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
|
|
WO2005044858A1
(en)
|
2003-11-07 |
2005-05-19 |
Ablynx N.V. |
Camelidae single domain antibodies vhh directed against epidermal growth factor receptor and uses therefor
|
|
WO2004041867A2
(en)
|
2002-11-08 |
2004-05-21 |
Ablynx N.V. |
Camelidae antibodies against imminoglobulin e and use thereof for the treatment of allergic disorders
|
|
CN100570365C
(zh)
*
|
2002-11-14 |
2009-12-16 |
斯克里普斯研究所 |
抗体或嗜中性粒细胞介导的臭氧产生
|
|
US7297340B2
(en)
*
|
2003-01-07 |
2007-11-20 |
University Of Iowa Research Foundation |
Vaccine and method for preventing biofilm formation
|
|
EP1587838B1
(en)
|
2003-01-10 |
2015-04-15 |
Ablynx N.V. |
Therapeutic polypeptides, homologues thereof, fragments thereof and their use in modulating platelet-mediated aggregation
|
|
US20050079512A1
(en)
*
|
2003-02-26 |
2005-04-14 |
Emerson Beverly M. |
Methods of modulating gene expression
|
|
US7507727B2
(en)
*
|
2003-04-07 |
2009-03-24 |
Cylene Pharmaceuticals, Inc. |
Substituted quinobenzoxazine analogs and methods of using thereof
|
|
EP1610795A4
(en)
*
|
2003-04-07 |
2007-10-24 |
Cylene Pharmaceuticals Inc |
HETEROCYCLIC SUBSTITUTED 1,4-DIHYDRO-4-OXO-1,8-NAPHTHPYRIDINE ANALOGUE
|
|
EP1610759A4
(en)
|
2003-04-07 |
2007-04-25 |
Cylene Pharmaceuticals Inc |
SUBSTITUTED CHINOBENZOXAZINE ANALOGUE
|
|
US7354916B2
(en)
*
|
2003-04-07 |
2008-04-08 |
Cylene Pharmaceuticals |
Substituted quinobenzoxazine analogs
|
|
US7575739B2
(en)
|
2003-04-28 |
2009-08-18 |
Foamix Ltd. |
Foamable iodine composition
|
|
DE602004012279T3
(de)
|
2003-06-25 |
2010-07-15 |
The Burnham Institute, La Jolla |
Katecholderivate zur behandlung von krebs
|
|
WO2005003140A1
(en)
*
|
2003-07-02 |
2005-01-13 |
Pharmacia & Upjohn Company Llc |
4-oxo-4,7-dihydrothieno[2,3-b]pyridine-5-carboxamides as antiviral agents
|
|
WO2005009406A1
(en)
*
|
2003-07-18 |
2005-02-03 |
Hill Dermaceuticals, Inc. |
Topical skin care composition containing refined peanut oil
|
|
US20070140999A1
(en)
*
|
2003-07-18 |
2007-06-21 |
Hill Dermaceuticals, Inc. |
Topical skin care composition containing refined peanut oil
|
|
US8795693B2
(en)
|
2003-08-04 |
2014-08-05 |
Foamix Ltd. |
Compositions with modulating agents
|
|
US8486374B2
(en)
*
|
2003-08-04 |
2013-07-16 |
Foamix Ltd. |
Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
|
|
ES2557310T3
(es)
|
2003-08-25 |
2016-01-25 |
Dogwood Pharmaceuticals, Inc. |
8-heteroaril xantinas substituidas
|
|
US9532994B2
(en)
|
2003-08-29 |
2017-01-03 |
The Regents Of The University Of California |
Agents and methods for enhancing bone formation by oxysterols in combination with bone morphogenic proteins
|
|
US20060099173A1
(en)
*
|
2003-10-24 |
2006-05-11 |
Nancy Puglia |
Topical skin care composition
|
|
AU2004305075A1
(en)
*
|
2003-12-19 |
2005-07-07 |
The Regents Of The University Of California |
Methods and materials for assessing prostate cancer therapies
|
|
EP1727522A2
(en)
*
|
2004-02-04 |
2006-12-06 |
Foamix Ltd. |
Cosmetic and pharmaceutical foam with solid matter
|
|
WO2005077377A1
(en)
*
|
2004-02-06 |
2005-08-25 |
Regents Of The University Of Minnesota |
Compositions that include a triterpene and a carrier
|
|
JP4934432B2
(ja)
|
2004-02-19 |
2012-05-16 |
レクサン ファーマシューティカルズ インコーポレイテッド |
キナゾリン誘導体およびキナゾリン誘導体の治療への使用
|
|
US20050187191A1
(en)
*
|
2004-02-20 |
2005-08-25 |
Kucera Louis S. |
Methods and compositions for the treatment of respiratory syncytial virus
|
|
US20050187192A1
(en)
*
|
2004-02-20 |
2005-08-25 |
Kucera Pharmaceutical Company |
Phospholipids for the treatment of infection by togaviruses, herpes viruses and coronaviruses
|
|
NZ550102A
(en)
*
|
2004-02-24 |
2010-10-29 |
Univ California |
Methods and materials for assessing prostate cancer therapies and compounds (thiohydantoine derivatives)
|
|
AU2005228410A1
(en)
|
2004-03-29 |
2005-10-13 |
University Of South Florida |
Effective treatment of tumors and cancer with triciribine and related compounds
|
|
AU2005267706B2
(en)
|
2004-08-02 |
2011-12-08 |
University Of Virginia Patent Foundation |
2-propynyl adenosine analogs with modified 5'-ribose groups having A2A agonist activity
|
|
US7576069B2
(en)
*
|
2004-08-02 |
2009-08-18 |
University Of Virginia Patent Foundation |
2-polycyclic propynyl adenosine analogs having A2A agonist activity
|
|
WO2006026380A2
(en)
*
|
2004-08-25 |
2006-03-09 |
University Of Iowa Research Foundation |
Geranylgeranyl pyrophosphate synthase inhibitors
|
|
US7718680B2
(en)
*
|
2004-09-23 |
2010-05-18 |
Burnham Institute For Medical Research |
Inhibition of lethal factor protease activity from anthrax toxin
|
|
WO2006040153A2
(en)
*
|
2004-10-13 |
2006-04-20 |
Ablynx N.V. |
Single domain camelide anti -amyloid beta antibodies and polypeptides comprising the same for the treatment and diagnosis of degenarative neural diseases such as alzheimer's disease
|
|
US8697674B2
(en)
|
2004-12-29 |
2014-04-15 |
Naturon, Inc. |
Xanthurenic acid derivative pharmaceutical compositions and methods related thereto
|
|
EP1845778A2
(en)
*
|
2005-01-10 |
2007-10-24 |
University Of Virginia Patent Foundation |
Synthesis of inhibitors of p90rsk
|
|
AU2006298442A1
(en)
*
|
2005-05-09 |
2007-04-12 |
Foamix Ltd. |
Saccharide foamable compositions
|
|
JP4644737B2
(ja)
|
2005-05-13 |
2011-03-02 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
ジアリールヒダントイン化合物
|
|
US7709517B2
(en)
|
2005-05-13 |
2010-05-04 |
The Regents Of The University Of California |
Diarylhydantoin compounds
|
|
WO2006122787A1
(en)
|
2005-05-18 |
2006-11-23 |
Ablynx Nv |
Serum albumin binding proteins
|
|
ES2852423T3
(es)
|
2005-05-20 |
2021-09-13 |
Ablynx Nv |
NanobodiesTM mejorados para el tratamiento de trastornos mediados por agregación
|
|
WO2006129161A2
(en)
|
2005-06-01 |
2006-12-07 |
Stiefel Research Australia Pty Ltd |
Vitamin formulation
|
|
US20080152596A1
(en)
*
|
2005-07-19 |
2008-06-26 |
Foamix Ltd. |
Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
|
|
WO2007019308A2
(en)
*
|
2005-08-03 |
2007-02-15 |
The Regents Of The University Of California |
Illudin analogs useful as anticancer agents
|
|
ES2577514T3
(es)
|
2005-08-22 |
2016-07-15 |
The Regents Of The University Of California |
Antagonistas de TLR
|
|
US20070098667A1
(en)
*
|
2005-10-27 |
2007-05-03 |
Jim Taneri |
Methods and compositions for epilation
|
|
US20070098660A1
(en)
*
|
2005-10-27 |
2007-05-03 |
Jim Taneri |
Methods and compositions for epilation
|
|
US20090291437A1
(en)
*
|
2005-11-02 |
2009-11-26 |
O'brien Sean |
Methods for targeting quadruplex sequences
|
|
WO2007120972A2
(en)
*
|
2006-02-10 |
2007-10-25 |
University Of Virginia Patent Foundation |
Method to treat sickle cell disease
|
|
US9670244B2
(en)
|
2006-02-27 |
2017-06-06 |
The Regents Of The University Of California |
Oxysterol compounds and the hedgehog pathway
|
|
CA2647038A1
(en)
*
|
2006-03-22 |
2007-10-04 |
The Regents Of The University Of California |
Inhibitors of protein prenyltransferases
|
|
LT2656842T
(lt)
|
2006-03-27 |
2016-09-26 |
The Regents Of The University Of California |
Androgeno receptoriaus moduliatorius, skirtas prostatos vėžio ir su androgeno receptoriumi susijusių ligų gydymui
|
|
KR101456722B1
(ko)
*
|
2006-03-29 |
2014-10-31 |
더 리전트 오브 더 유니버시티 오브 캘리포니아 |
디아릴티오히단토인 화합물
|
|
US8093235B2
(en)
|
2006-04-25 |
2012-01-10 |
Rutgers, The State University Of New Jersey |
Macrocyclic compounds which stabilize G-Quadruplex DNA and RNA
|
|
WO2007139778A2
(en)
*
|
2006-05-22 |
2007-12-06 |
University Of Virginia Patent Foundation |
Rhamnose substituents of sl0101 and therapeutic uses thereof
|
|
WO2007146813A2
(en)
*
|
2006-06-08 |
2007-12-21 |
Cylene Pharmaceuticals, Inc. |
Pyridinone analogs as cell proliferation inhibitors
|
|
WO2007146831A2
(en)
*
|
2006-06-08 |
2007-12-21 |
Cylene Pharmaceuticals, Inc. |
Quinolone analogs derivatized with sulfonic acid, sulfonate or sulfonamide
|
|
US8188063B2
(en)
*
|
2006-06-19 |
2012-05-29 |
University Of Virginia Patent Foundation |
Use of adenosine A2A modulators to treat spinal cord injury
|
|
JP2010502690A
(ja)
*
|
2006-09-08 |
2010-01-28 |
フォーミックス エルティーディー． |
有色または着色可能発泡性組成物
|
|
EP2073794A2
(en)
*
|
2006-11-14 |
2009-07-01 |
Foamix Ltd. |
Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses
|
|
US20080260655A1
(en)
*
|
2006-11-14 |
2008-10-23 |
Dov Tamarkin |
Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
|
|
US8034829B2
(en)
|
2006-11-17 |
2011-10-11 |
Rexahn Pharmaceuticals, Inc. |
5, 6, or 7-substituted-3-(hetero)arylisoquinolinamine derivatives and therapeutic use thereof
|
|
WO2008065503A1
(en)
*
|
2006-11-29 |
2008-06-05 |
Pfizer Products Inc. |
(r) -5-methyl-4, 5-dihydro- pyrazole-1, 5-dicarboxylic acid 1- [ ( 4 -chlorophenyl) amide 5-{ [2-fluoro-4- (2-oxo-2h-pyridin-1-yl) -phenyl]amide) as a factor xa inhibitor
|
|
WO2008074839A2
(en)
|
2006-12-19 |
2008-06-26 |
Ablynx N.V. |
Amino acid sequences directed against gpcrs and polypeptides comprising the same for the treatment of gpcr-related diseases and disorders
|
|
EP2102244A2
(en)
|
2006-12-19 |
2009-09-23 |
Ablynx N.V. |
Amino acid sequences directed against a metalloproteinase from the adam family and polypeptides comprising the same for the treatment of adam-related diseases and disorders
|
|
AU2008213666B2
(en)
|
2007-02-06 |
2013-11-07 |
University Of Louisville Research Foundation, Inc. |
Substituted alkine derivatives as anti-cancer agents
|
|
ES2552471T3
(es)
|
2007-02-07 |
2015-11-30 |
The Regents Of The University Of California |
Conjugados de agonistas de TLR sintéticos y usos de los mismos
|
|
WO2008103818A1
(en)
*
|
2007-02-21 |
2008-08-28 |
University Of Louisville Research Foundation |
Therapeutic cotinine compositions
|
|
WO2009073186A1
(en)
|
2007-12-03 |
2009-06-11 |
The Regents Of The University Of California |
Oxsterols for activation of hedgehog signaling, osteoinduction, antiadipogenesis, and wnt signaling
|
|
WO2008138001A2
(en)
|
2007-05-08 |
2008-11-13 |
University Of Louisville Research Foundation |
Synthetic peptides and peptide mimetics
|
|
EP2173352B1
(en)
|
2007-07-12 |
2016-09-07 |
University of South Florida |
Inhibitors of akt/pkb with anti-tumor activity
|
|
MX2010001303A
(es)
|
2007-08-02 |
2010-09-07 |
Univ Rutgers |
Compuestos terapeuticos.
|
|
US8636982B2
(en)
|
2007-08-07 |
2014-01-28 |
Foamix Ltd. |
Wax foamable vehicle and pharmaceutical compositions thereof
|
|
PL3092901T3
(pl)
|
2007-10-05 |
2020-10-19 |
Senhwa Biosciences, Inc. |
Analogi chinolonu i sposoby z nimi związane
|
|
AU2008311827A1
(en)
|
2007-10-19 |
2009-04-23 |
Burnham Institute For Medical Research |
Naphthalene-based inhibitors of anti-apoptotic proteins
|
|
WO2009055677A1
(en)
*
|
2007-10-24 |
2009-04-30 |
University Of South Florida |
Antibacterial s-heterosubstituted disulfides
|
|
TWI469971B
(zh)
|
2007-10-26 |
2015-01-21 |
Univ California |
二芳基乙內醯脲類化合物
|
|
US20090130029A1
(en)
*
|
2007-11-21 |
2009-05-21 |
Foamix Ltd. |
Glycerol ethers vehicle and pharmaceutical compositions thereof
|
|
WO2009069006A2
(en)
|
2007-11-30 |
2009-06-04 |
Foamix Ltd. |
Foam containing benzoyl peroxide
|
|
US8518376B2
(en)
|
2007-12-07 |
2013-08-27 |
Foamix Ltd. |
Oil-based foamable carriers and formulations
|
|
WO2009072007A2
(en)
*
|
2007-12-07 |
2009-06-11 |
Foamix Ltd. |
Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
|
|
US8058259B2
(en)
*
|
2007-12-20 |
2011-11-15 |
University Of Virginia Patent Foundation |
Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists
|
|
CA2712120A1
(en)
*
|
2008-01-14 |
2009-07-23 |
Foamix Ltd. |
Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
|
|
WO2009108716A2
(en)
|
2008-02-27 |
2009-09-03 |
University Of Louisville Research Foundation |
Synthetic peptides
|
|
WO2009114539A2
(en)
*
|
2008-03-10 |
2009-09-17 |
University Of Louisville Research Foundation |
Neuroprotective integrin-binding peptide and angiopoietin-1 treatments
|
|
US20110046101A1
(en)
*
|
2008-03-17 |
2011-02-24 |
Dmitrienko Gary I |
Bate-lactamase inhibitors
|
|
WO2009146112A1
(en)
*
|
2008-04-02 |
2009-12-03 |
University Of Virginia Patent Foundation |
Compositions and methods for inhibiting sphingosine kinase
|
|
AU2009235467A1
(en)
|
2008-04-07 |
2009-10-15 |
Ablynx Nv |
Single variable domains against the Notch pathways
|
|
AU2009236303B2
(en)
|
2008-04-16 |
2014-12-04 |
Howard University |
Inhibitors of Protein Phosphatase-1 and uses thereof
|
|
NZ589036A
(en)
|
2008-05-16 |
2012-07-27 |
Ablynx Nv |
AMINO ACID SEQUENCES DIRECTED AGAINST CXCR4 AND OTHER GPCRs AND COMPOUNDS COMPRISING THE SAME
|
|
US9872867B2
(en)
*
|
2008-06-06 |
2018-01-23 |
Tanya Kuritz |
Methods and compositions for modulation of innate immunity
|
|
US20090324506A1
(en)
*
|
2008-06-30 |
2009-12-31 |
Jeffery Richard Seidling |
Sprayable skin protectant formulation and method of use
|
|
WO2010005534A2
(en)
*
|
2008-06-30 |
2010-01-14 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Proteasome inhibitors for selectively inducing apoptosis in cancer cells
|
|
US7947717B2
(en)
*
|
2008-07-18 |
2011-05-24 |
Burnham Institute For Medical Research |
Inhibitors of lethal factor protease
|
|
WO2010011666A2
(en)
*
|
2008-07-21 |
2010-01-28 |
University Of South Florida |
Indoline scaffold shp-2 inhibitors and cancer treatment method
|
|
US9125821B2
(en)
|
2008-07-28 |
2015-09-08 |
The Regents Of The University Of California |
Nanodrug targeting protein geranylgeranylation
|
|
WO2010014054A1
(en)
|
2008-07-28 |
2010-02-04 |
The Regents Of The University Of California |
Inhibitors of protein prenyltransferases
|
|
US9132168B2
(en)
|
2008-08-05 |
2015-09-15 |
University Of South Florida |
Methods of treating cognitive impairment
|
|
CA2733126A1
(en)
*
|
2008-08-05 |
2010-02-11 |
University Of South Florida |
Methods of treating cognitive impairment
|
|
JP2011530539A
(ja)
*
|
2008-08-08 |
2011-12-22 |
ユニバーシティ オブ フロリダ リサーチ ファウンデーション，インク． |
腫瘍形成を抑制する脂質化合物
|
|
US9480691B1
(en)
*
|
2009-01-20 |
2016-11-01 |
Hill Dermaceuticals, Inc. |
Topical liquid containing refined peanut oil for treating skin proliferation or inflammation disorders
|
|
TW201038578A
(en)
|
2009-01-30 |
2010-11-01 |
Univ Rutgers |
Methods to treat cancer
|
|
CN102438619A
(zh)
|
2009-03-20 |
2012-05-02 |
衣阿华大学研究基金会 |
作为抗结核剂的异戊二烯化双膦酸盐
|
|
NZ595461A
(en)
|
2009-04-10 |
2013-01-25 |
Ablynx Nv |
Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders
|
|
BRPI1016102A2
(pt)
|
2009-04-15 |
2015-09-01 |
Sanford Burhnham Medical Res Inst |
Inibidores de proteínas anti-apoptótica baseados em naftaleno
|
|
US8487131B2
(en)
|
2009-04-15 |
2013-07-16 |
Sanford-Burnham Medical Research Institute |
Optically pure apogossypol derivative as pan-active inhibitor of anti-apoptotic B-cell lymphoma/leukemia-2 (BCL-2)
|
|
US20120087872A1
(en)
|
2009-04-28 |
2012-04-12 |
Foamix Ltd. |
Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
|
|
EP3670509B1
(en)
|
2009-05-13 |
2023-04-19 |
University of Virginia Patent Foundation |
Inhibitors of inv(16) leukemia
|
|
EA201270102A1
(ru)
|
2009-06-30 |
2012-08-30 |
Форест Лэборетериз Холдингз Лимитед |
Соединения алкокси-карбонил-амино-алкинил-аденозина и их производные в качестве агонистов ar
|
|
WO2011005871A1
(en)
|
2009-07-07 |
2011-01-13 |
Pgxhealth, Llc |
Substituted 8-[6-carbonylamine-3-pyridyl]xanthines as adenosine a2b antagonists
|
|
CA2769625C
(en)
|
2009-07-29 |
2017-04-11 |
Foamix Ltd. |
Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
|
|
WO2011013008A2
(en)
|
2009-07-29 |
2011-02-03 |
Foamix Ltd. |
Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
|
|
RU2012107101A
(ru)
|
2009-07-31 |
2013-09-10 |
Байокрист Фармасьютикалз, Инк. |
Производные пирроло[1,2-в] пиридазина как ингибиторы янус-киназы
|
|
WO2011019995A2
(en)
|
2009-08-14 |
2011-02-17 |
Hecht Sidney M |
Synthesis and identification of novel rsk-specific inhibitors
|
|
TW201111385A
(en)
|
2009-08-27 |
2011-04-01 |
Biocryst Pharm Inc |
Heterocyclic compounds as janus kinase inhibitors
|
|
US8642088B2
(en)
|
2009-09-04 |
2014-02-04 |
Wisconsin Alumni Research Foundation |
Tannin-chitosan composites
|
|
US9849142B2
(en)
|
2009-10-02 |
2017-12-26 |
Foamix Pharmaceuticals Ltd. |
Methods for accelerated return of skin integrity and for the treatment of impetigo
|
|
US10029013B2
(en)
|
2009-10-02 |
2018-07-24 |
Foamix Pharmaceuticals Ltd. |
Surfactant-free, water-free formable composition and breakable foams and their uses
|
|
KR20120060234A
(ko)
*
|
2009-10-08 |
2012-06-11 |
샌포드-번햄 메디칼 리서치 인스티튜트 |
항암제로서의 아포고시폴론 유도체
|
|
EP2496704A4
(en)
|
2009-11-05 |
2013-05-01 |
Univ Rutgers |
THERAPEUTIC COMPOUNDS
|
|
EP2516444A2
(en)
|
2009-12-23 |
2012-10-31 |
Biocryst Pharmaceuticals, Inc. |
Heterocyclic compounds as janus kinase inhibitors
|
|
CN102892755A
(zh)
|
2009-12-23 |
2013-01-23 |
韦恩州立大学 |
治疗性化合物
|
|
WO2011103202A2
(en)
|
2010-02-16 |
2011-08-25 |
Aragon Pharmaceuticals, Inc. |
Androgen receptor modulators and uses thereof
|
|
US20120329770A1
(en)
|
2010-02-26 |
2012-12-27 |
Gary Igor Dmitrienko |
Cephalosporin derivatives useful as beta-lactamase inhibitors and compositions and methods of use thereof
|
|
WO2011123856A1
(en)
|
2010-04-02 |
2011-10-06 |
Tsrl, Inc. |
Neuraminidase inhibitors
|
|
WO2011130740A2
(en)
|
2010-04-16 |
2011-10-20 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Pyridylthiazole-based ureas as inhibitors of rho associated protein kinase (rock) and methods of use
|
|
WO2011133696A2
(en)
|
2010-04-20 |
2011-10-27 |
Regents Of The University Of Minnesota |
Methods of suppressing atherosclerosis
|
|
AU2011258005A1
(en)
|
2010-05-28 |
2013-01-17 |
Biocryst Pharmaceuticals, Inc. |
Heterocyclic compounds as Janus kinase inhibitors
|
|
WO2012027494A1
(en)
|
2010-08-24 |
2012-03-01 |
Regents Of The University Of Minnesota |
Bispecific targeting reagents
|
|
US8609672B2
(en)
|
2010-08-27 |
2013-12-17 |
University Of The Pacific |
Piperazinylpyrimidine analogues as protein kinase inhibitors
|
|
IN2013CN00520A
(xx)
|
2010-09-20 |
2015-04-24 |
Oreal |
|
|
ES2533598T3
(es)
|
2010-09-20 |
2015-04-13 |
L'oréal |
Composición cosmética acuosa que comprende alquilcelulosa
|
|
AU2011323784A1
(en)
|
2010-10-25 |
2013-05-30 |
Regents Of The University Of Minnesota |
Therapeutic composition for treatment of glioblastoma
|
|
UA113507C2
(xx)
|
2011-02-07 |
2017-02-10 |
|
Модулятори s1p
|
|
WO2012122219A2
(en)
|
2011-03-07 |
2012-09-13 |
University Of Louisville Research Foundation |
Predictive marker of dnmt1 inhibitor therapeutic efficacy and methods of using the marker
|
|
WO2012135697A2
(en)
|
2011-03-30 |
2012-10-04 |
H. Lee Moffitt Cancer Center & Research Institute Inc. |
Novel rho kinase inhibitors and methods of use
|
|
CN103826657A
(zh)
|
2011-04-04 |
2014-05-28 |
衣阿华大学研究基金会 |
改进疫苗免疫原性的方法
|
|
EP2694079B1
(en)
|
2011-04-06 |
2018-01-17 |
Rutgers, The State University of New Jersey |
Polymers and methods for the treatment of pain
|
|
US20120270860A1
(en)
|
2011-04-19 |
2012-10-25 |
Gihyun Yoon |
Methods for treating or preventing alcohol-related disorders or craving-related disorders
|
|
WO2012145678A1
(en)
|
2011-04-20 |
2012-10-26 |
Regents Of The University Of Minnesota |
Anti-cancer and anti-inflammatory parthenolide compounds
|
|
WO2012177770A1
(en)
|
2011-06-20 |
2012-12-27 |
Rutgers, The State University Of New Jersey |
Bipartite inhibitors of bacterial rna polymerase
|
|
WO2013009647A1
(en)
|
2011-07-08 |
2013-01-17 |
Regents Of The University Of Minnesota |
Glutathione analogs and uses thereof
|
|
US9167820B2
(en)
|
2011-07-22 |
2015-10-27 |
University Of Louisville Research Foundation, Inc. |
Anti-biofilm compounds
|
|
KR101923250B1
(ko)
|
2011-07-29 |
2018-11-28 |
메디베이션 프로스테이트 테라퓨틱스 엘엘씨 |
유방암의 치료
|
|
WO2013028866A1
(en)
|
2011-08-24 |
2013-02-28 |
Regents Of The University Of Minnesota |
Therapeutic compounds and methods
|
|
WO2013033345A1
(en)
|
2011-08-30 |
2013-03-07 |
Regents Of The University Of Minnesota |
Immunomodulators and immunomodulator conjugates
|
|
US9598441B2
(en)
|
2011-08-30 |
2017-03-21 |
Wayne State University |
Therapeutic compounds and methods
|
|
CA2846676C
(en)
|
2011-09-08 |
2020-06-23 |
Western University Of Health Sciences |
Cystine coupled targeting liposomes
|
|
EP2755942A2
(en)
|
2011-09-15 |
2014-07-23 |
Arizona Board of Regents, a Body Corporate of the State of Arizona acting for and on behalf of Arizona State University |
Therapeutic compounds
|
|
US9828326B2
(en)
*
|
2011-12-27 |
2017-11-28 |
Northeast Ohio Medical University |
Amooranin compounds and analogs thereof and related methods of use
|
|
FR2985176B1
(fr)
|
2012-01-02 |
2015-05-29 |
Oreal |
Composition cosmetique liquide aqueuse comprenant de l'alkylcellulose, des huiles non volatiles et au moins un tensioactif
|
|
WO2013103969A1
(en)
|
2012-01-05 |
2013-07-11 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: phloroglucinol derivatives
|
|
WO2013106572A1
(en)
|
2012-01-11 |
2013-07-18 |
Arizona Board Of Regents, A Body Corporate Of The State Of Arizona Acting For And On Behalf Of Arizona State University |
Bispecific antibody fragments for neurological disease proteins and methods of use
|
|
US8947424B2
(en)
|
2012-01-17 |
2015-02-03 |
Eastman Kodak Company |
Spectral stereoscopic projection system
|
|
EP3269372B1
(en)
|
2012-01-19 |
2019-06-12 |
Hybrid Medical, LLC |
Topical therapeutic formulations
|
|
EP2804852A2
(en)
|
2012-01-20 |
2014-11-26 |
Regents Of The University Of Minnesota |
Therapeutic compounds
|
|
WO2013113102A1
(en)
|
2012-02-01 |
2013-08-08 |
The Governors Of The University Of Alberta |
USE OF PDGFR-α AS DIAGNOSTIC MARKER FOR PAPILLARY THYROID CANCER
|
|
US20130195752A1
(en)
|
2012-02-01 |
2013-08-01 |
Regents Of The University Of Minnesota |
Functionalized nanoparticles and methods of use thereof
|
|
US9839634B2
(en)
|
2012-02-06 |
2017-12-12 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: combination of a rifamycin and a switch region inhibitor
|
|
EP2822548B1
(en)
|
2012-02-08 |
2019-04-24 |
University of Virginia Patent Foundation |
Long chain base sphingosine kinase inhibitors
|
|
WO2013142812A1
(en)
|
2012-03-22 |
2013-09-26 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: sidechain-fluorinated myxopyronin derivatives
|
|
CA2868508A1
(en)
|
2012-03-26 |
2013-10-03 |
University Of Iowa Research Foundation |
Schweinfurthin analogues
|
|
US9340501B2
(en)
|
2012-04-16 |
2016-05-17 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Marinopyrrole derivatives as anticancer agents
|
|
US9272016B2
(en)
|
2012-04-20 |
2016-03-01 |
University Of Iowa Research Foundation |
Methods to enhance RNAi oligonucleotide delivery to respiratory epithelial cells
|
|
KR20150013232A
(ko)
|
2012-05-07 |
2015-02-04 |
더 리전트 오브 더 유니버시티 오브 캘리포니아 |
골형성 및 헤지호그 신호전달을 유도하고 지방생성을 억제하는 옥시스테롤 유사체 oxy133
|
|
WO2013192352A1
(en)
|
2012-06-19 |
2013-12-27 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: aryl myxopyronin derivatives
|
|
WO2013192388A1
(en)
|
2012-06-20 |
2013-12-27 |
University Of Virginia Patent Foundation |
Compositions and methods for regulating glucose homeostasis and insulin action
|
|
US9669115B2
(en)
|
2012-06-29 |
2017-06-06 |
University Of Iowa Research Foundation |
Co-crystals and salts of contrast agents and imaging
|
|
ES2617448T3
(es)
|
2012-07-05 |
2017-06-19 |
University Of Iowa Research Foundation |
Bisfosfonatos terapéuticos
|
|
US9605002B2
(en)
|
2012-07-18 |
2017-03-28 |
University Of Notre Dame Du Lac |
5,5-heteroaromatic anti-infective compounds
|
|
WO2014018671A1
(en)
|
2012-07-24 |
2014-01-30 |
Regents Of The University Of Minnesota |
Therapeutic compounds for the treatment of cancer
|
|
MX363388B
(es)
|
2012-07-27 |
2019-03-20 |
Biogen Ma Inc |
Agentes moduladores de autotaxina.
|
|
IN2015DN00538A
(xx)
|
2012-08-01 |
2015-06-26 |
Lewis And Clark Pharmaceuticals Inc |
|
|
EP2880020B1
(en)
|
2012-08-03 |
2018-11-28 |
The Board of Trustees of the University of Illionis |
Enzyme-activating compounds and compositions
|
|
WO2014025709A1
(en)
|
2012-08-06 |
2014-02-13 |
Biogen Idec Ma Inc. |
Compounds that are s1p modulating agents and/or atx modulating agents
|
|
WO2014025708A1
(en)
|
2012-08-06 |
2014-02-13 |
Biogen Idec Ma Inc. |
Compounds that are s1p modulating agents and/or atx modulating agents
|
|
CA3139033A1
(en)
|
2012-08-22 |
2014-02-27 |
Cornell University |
Methods for inhibiting fascin
|
|
US9737493B2
(en)
|
2012-09-07 |
2017-08-22 |
University Of Louisville Research Foundation, Inc. |
Compositions and methods for modulating DNMT1 inhibitor activity
|
|
WO2014043252A2
(en)
|
2012-09-11 |
2014-03-20 |
Rutgers, The State University Of New Jersey |
Therapeutic hydroxypyridinones, hydroxypyrimidinones and hydroxypyridazinones
|
|
SG11201501870RA
(en)
|
2012-09-26 |
2015-04-29 |
Aragon Pharmaceuticals Inc |
Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer
|
|
JP2016501832A
(ja)
|
2012-10-10 |
2016-01-21 |
アリゾナ ボード オブ リージェンツ オン ビハーフ オブ アリゾナ ステート ユニバーシティ |
多機能ラジカル消光剤
|
|
US9364406B2
(en)
|
2012-10-12 |
2016-06-14 |
Regents Of The University Of Minnesota |
Open chained or fused 1,1′-alkylene-bis-uracil derivatives, useful in skin UV-protection
|
|
US9296730B2
(en)
|
2012-10-26 |
2016-03-29 |
Regents Of The University Of Minnesota |
Aurora kinase inhibitors
|
|
WO2014070774A1
(en)
|
2012-10-29 |
2014-05-08 |
Southern Methodist University |
Methods of generating beta-lactamase resistant carbapenem compounds
|
|
WO2014074926A1
(en)
|
2012-11-09 |
2014-05-15 |
Rutgers, The State University Of New Jersey |
Therapeutic hydroxyquinolones
|
|
WO2014078778A2
(en)
|
2012-11-16 |
2014-05-22 |
Biocryst Pharmaceuticals, Inc. |
Antiviral azasugar-containing nucleosides
|
|
WO2014078857A1
(en)
|
2012-11-19 |
2014-05-22 |
Regents Of The University Of Minnesota |
Ergoline derivatives as dopamine receptor modulators
|
|
WO2014081756A1
(en)
|
2012-11-20 |
2014-05-30 |
Biogen Idec Ma Inc. |
S1p and/or atx modulating agents
|
|
ES2636596T3
(es)
|
2012-11-20 |
2017-10-06 |
Biogen Ma Inc. |
Agentes moduladores de S1P y/o ATX
|
|
SG10201907684PA
(en)
|
2013-01-15 |
2019-10-30 |
Aragon Pharmaceuticals Inc |
Androgen receptor modulator and uses thereof
|
|
US9700044B2
(en)
|
2013-01-22 |
2017-07-11 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Symmetrical marinopyrrole derivatives as potential antibiotic agents
|
|
CA2899322A1
(en)
|
2013-01-29 |
2014-08-07 |
Biogen Ma Inc. |
S1p modulating agents
|
|
US9981043B2
(en)
|
2013-02-08 |
2018-05-29 |
Regents Of The University Of Minnesota |
Analgesic conjugates
|
|
JP2016510749A
(ja)
|
2013-03-05 |
2016-04-11 |
ユニヴァーシティー オブ ノートル ダム デュ ラック |
キナゾリノン抗生物質
|
|
EP2970334B1
(en)
|
2013-03-15 |
2018-05-23 |
Biogen MA Inc. |
Macrocyclic compounds as irak4 inhibitors for the treatment of inflammatory diseases
|
|
US9387250B2
(en)
|
2013-03-15 |
2016-07-12 |
Rutgers, The State University Of New Jersey |
Therapeutic compositions for bone repair
|
|
JP2016519672A
(ja)
|
2013-03-15 |
2016-07-07 |
ジェネンテック， インコーポレイテッド |
ブロモドメイン含有タンパク質ｂｒｄ７およびｂｒｄ９の阻害によるｔｈ２媒介性疾患の治療
|
|
US20160039825A1
(en)
|
2013-03-15 |
2016-02-11 |
Biogen Ma Inc. |
S1p and/or atx modulating agents
|
|
CN105263500A
(zh)
|
2013-05-02 |
2016-01-20 |
加利福尼亚大学董事会 |
骨选择性成骨性氧固醇-骨靶向剂
|
|
WO2014194055A1
(en)
|
2013-05-29 |
2014-12-04 |
Rutgers, The State University Of New Jersey |
Antioxidant-based poly(anhydride-esters)
|
|
US9987211B2
(en)
|
2013-07-03 |
2018-06-05 |
Regents Of The University Of Minnesota |
Sunless tanning compounds and compositions
|
|
US9850216B2
(en)
|
2013-08-06 |
2017-12-26 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Inhibitors of ACK1/TNK2 tyrosine kinase
|
|
CN112353791B
(zh)
|
2013-11-11 |
2025-02-25 |
夸利蒂赫布丘蒂克斯公司 |
卡瓦衍生的治疗性化合物及其使用方法
|
|
US9339482B2
(en)
|
2013-11-22 |
2016-05-17 |
Regents Of The University Of Minnesota |
Methods to treat dysregulated blood glucose disorders
|
|
US9315523B2
(en)
|
2013-12-06 |
2016-04-19 |
Rutgers, The State University Of New Jersey |
Cyclic dinucleosides
|
|
EP3102193B1
(en)
|
2014-02-06 |
2023-01-11 |
Rutgers, The State University of New Jersey |
Antibacterial agents: n(alpha)-aroyl-n-aryl-phenylalaninamides
|
|
CN111349087B
(zh)
|
2014-02-20 |
2023-07-14 |
康奈尔大学 |
用于抑制肌成束蛋白的化合物和方法
|
|
US10189874B2
(en)
|
2014-02-26 |
2019-01-29 |
Arizona Board Of Regents On Behalf Of Arizona State University |
DNA gridiron compositions and methods
|
|
US10272055B2
(en)
|
2014-03-06 |
2019-04-30 |
Regents Of The University Of Minnesota |
Therapeutic compounds and methods
|
|
CN106257976B
(zh)
|
2014-03-07 |
2021-02-02 |
拜奥克里斯特制药公司 |
人类血浆激肽释放酶抑制剂
|
|
US10197575B2
(en)
|
2014-03-31 |
2019-02-05 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Stabilized peptoid-peptide hybrids and uses thereof
|
|
CA2946112C
(en)
|
2014-04-18 |
2020-11-24 |
The Governors Of The University Of Alberta |
Targeted therapy to restore radioactive iodine transport in thyroid cancer
|
|
US9556113B2
(en)
|
2014-04-29 |
2017-01-31 |
The South Dakota Board Of Regents |
Combination uses of dichloroacetate and oxamate, and their prodrugs, for cancer treatment
|
|
CA2945404A1
(en)
|
2014-05-02 |
2015-11-05 |
The Regents Of The University Of California |
Bone-selective osteogenic oxysterol bisphosphonate analogs
|
|
US9987299B2
(en)
|
2014-05-05 |
2018-06-05 |
University Of Iowa Research Foundation |
Methods of improving RNAi in well-differentiated airway epithelia
|
|
TW201613917A
(en)
|
2014-06-06 |
2016-04-16 |
Biogen Ma Inc |
ATX modulating agents
|
|
US10138203B2
(en)
|
2014-06-16 |
2018-11-27 |
Rutgers, The State University Of New Jersey |
Antibacterial agents
|
|
US9737598B2
(en)
|
2014-06-30 |
2017-08-22 |
Regents Of The University Of Minnesota |
CD200 inhibitors and methods of use thereof
|
|
KR102299276B1
(ko)
*
|
2014-07-16 |
2021-09-09 |
(주)아모레퍼시픽 |
납떼기콩 오일을 포함하는 조성물
|
|
EP3265130B1
(en)
|
2014-08-19 |
2024-05-22 |
Hsiri Therapeutics, LLC |
Antibacterial sideromycins
|
|
WO2016040801A1
(en)
|
2014-09-11 |
2016-03-17 |
University Of Iowa Research Foundation |
Thymol and carvacol for use in medicine
|
|
WO2016076929A1
(en)
|
2014-11-13 |
2016-05-19 |
University Of Iowa Research Foundation |
Methods to generate epithelial cells
|
|
WO2016133995A1
(en)
|
2015-02-17 |
2016-08-25 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Phenothiazine analogues as mitochondrial therapeutic agents
|
|
US10364227B2
(en)
|
2015-02-17 |
2019-07-30 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Therapeutic compounds
|
|
WO2016172187A1
(en)
|
2015-04-20 |
2016-10-27 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Methods and compositions related to kras inhibitors
|
|
JP6959142B2
(ja)
|
2015-05-06 |
2021-11-02 |
エイチ リー モフィット キャンサー センター アンド リサーチ インスティテュート インコーポレイテッド |
Ｍｃ１ｒを標的とする放射線療法用作用物質およびコンパニオンイメージング作用物質
|
|
CN108026084A
(zh)
|
2015-05-07 |
2018-05-11 |
夸利蒂赫布丘蒂克斯公司 |
治疗化合物及其使用方法
|
|
EP3297655B1
(en)
|
2015-05-18 |
2020-04-15 |
Arizona Board of Regents on Behalf of the University of Arizona |
Enhanced melanoma cancer prevention by novel melanotropins
|
|
WO2016205397A2
(en)
|
2015-06-15 |
2016-12-22 |
Klibanov Alexander L |
Target-specific delivery of therapeutic agents
|
|
WO2016205534A1
(en)
|
2015-06-16 |
2016-12-22 |
Lazo John S |
Inhibitors of ptp4a3 for the treatment of cancer
|
|
WO2017011686A1
(en)
|
2015-07-14 |
2017-01-19 |
University Of Iowa Research Foundation |
Fluorescent prodrugs
|
|
EP3328372A4
(en)
|
2015-07-28 |
2019-03-20 |
University Of Iowa Research Foundation |
COMPOSITIONS AND METHOD FOR THE TREATMENT OF CANCER
|
|
WO2017023899A1
(en)
|
2015-08-02 |
2017-02-09 |
H. Lee Moffitt Cancer Center & Research Institute |
Inhibitors of ack1/tnk2 tyrosine kinase
|
|
EP3334430B1
(en)
|
2015-08-13 |
2025-02-26 |
San Diego State University Research Foundation |
Atropisomerism for increased kinase inhibitor selectivity
|
|
CN109153679B
(zh)
|
2015-09-04 |
2022-04-08 |
詹森药业有限公司 |
用于疼痛的治疗性化合物及其合成
|
|
JP7097070B2
(ja)
|
2015-10-01 |
2022-07-07 |
ゴレイニ インコーポレイテッド |
クロライドチャネルの標的発現及びその使用方法
|
|
MY198346A
(en)
|
2015-10-01 |
2023-08-28 |
Biocryst Pharm Inc |
Human plasma kallikrein inhibitors
|
|
US10738016B2
(en)
|
2015-10-13 |
2020-08-11 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
BRD4-kinase inhibitors as cancer therapeutics
|
|
US10888609B2
(en)
|
2015-11-03 |
2021-01-12 |
Regents Of The University Of Minnesota |
CD200 inhibitors and methods of use thereof
|
|
WO2017087235A1
(en)
|
2015-11-20 |
2017-05-26 |
Senhwa Biosciences, Inc. |
Combination therapy of tetracyclic quinolone analogs for treating cancer
|
|
US9957282B2
(en)
|
2015-12-14 |
2018-05-01 |
Senhwa Biosciences, Inc. |
Crystalline forms of quinolone analogs and their salts
|
|
US9980951B2
(en)
|
2015-12-17 |
2018-05-29 |
University Of Iowa Research Foundation |
Image guided therapy for cancer
|
|
ES2950484T3
(es)
|
2015-12-21 |
2023-10-10 |
Oreal |
Composición que comprende alquilcelulosa, aceites de hidrocarburo y de silicona incompatibles, y método que la emplea
|
|
TWI726969B
(zh)
|
2016-01-11 |
2021-05-11 |
比利時商健生藥品公司 |
用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物
|
|
TWI854164B
(zh)
|
2016-02-01 |
2024-09-01 |
美商百歐克斯製藥公司 |
苯并吡唑化合物及其類似物
|
|
WO2017156527A1
(en)
|
2016-03-11 |
2017-09-14 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Aurora kinase and janus kinase inhibitors for prevention of graft versus host disease
|
|
US11395820B2
(en)
|
2016-03-16 |
2022-07-26 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Small molecules against cereblon to enhance effector t cell function
|
|
AU2017238208B2
(en)
|
2016-03-22 |
2022-01-06 |
Regents Of The University Of Minnesota |
Combination for treating pain
|
|
US10759740B2
(en)
|
2016-03-24 |
2020-09-01 |
Rutgers, The State University Of New Jersey |
Antibacterial agents
|
|
US11091498B2
(en)
|
2016-04-04 |
2021-08-17 |
Rutgers, The State University Of New Jersey |
Topoisomerase poisons
|
|
US10551384B2
(en)
|
2016-04-07 |
2020-02-04 |
Rutgers, The State University Of New Jersey |
MTOR kinase mutations and methods of use thereof
|
|
ES2946991T3
(es)
|
2016-04-18 |
2023-07-31 |
Gene Pool Tech Inc |
Aislamiento de extractos de plantas
|
|
RU2018142711A
(ru)
|
2016-05-04 |
2020-06-04 |
Х. Ли Моффитт Кэнсер Сентер Энд Рисёч Инститьют, Инк. |
Средство для целенаправленного воздействия на дельта-опиоидный рецептор для молекулярной визуализации и иммунотерапии рака
|
|
US10899793B2
(en)
|
2016-05-27 |
2021-01-26 |
Regents Of The University Of Minnesota |
Melanocortin ligands and methods of use thereof
|
|
JP2019526617A
(ja)
|
2016-06-20 |
2019-09-19 |
ラトガース ザ ステイト ユニバーシティー オブ ニュージャージー |
治療用化合物
|
|
AU2017281940C1
(en)
|
2016-06-24 |
2024-11-07 |
University Of Iowa Research Foundation |
Compositions and methods of treating melanoma
|
|
US10918647B2
(en)
|
2016-07-26 |
2021-02-16 |
University Of Southern California |
Selective bromodomain inhibition of fungal Bdf1
|
|
US11390605B2
(en)
|
2016-08-25 |
2022-07-19 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Substituted pyrimidine compounds as multifunctional radical quenchers and their uses
|
|
MX377365B
(es)
|
2016-09-08 |
2025-03-10 |
Journey Medical Corp |
Composiciones y métodos para tratar rosácea y acné.
|
|
PE20190980A1
(es)
|
2016-10-17 |
2019-07-09 |
Genentech Inc |
Compuestos terapeuticos y metodos para utilizarlos
|
|
US11124541B2
(en)
|
2016-10-18 |
2021-09-21 |
Regents Of The University Of Minnesota |
Chimeric melanocortin ligands and methods of use thereof
|
|
AU2017348305B2
(en)
|
2016-10-31 |
2022-04-21 |
Biocryst Pharmaceuticals, Inc. |
Prodrugs of kallikrein inhibitors
|
|
US11071747B2
(en)
|
2016-11-29 |
2021-07-27 |
University Of Iowa Research Foundation |
Use of NAD precursors for breast enhancement
|
|
JP7136795B2
(ja)
|
2016-11-29 |
2022-09-13 |
ユニバーシティー オブ アイオワ リサーチ ファウンデーション |
母体の健康および／または子の健康を向上させるためのｎａｄ前駆体の使用
|
|
US10710957B2
(en)
|
2017-01-09 |
2020-07-14 |
University Of Central Florida Research Foundation, Inc. |
Motuporamine derivatives as antimicrobial agents and antibiotic enhancers against resistant gram-negative bacteria
|
|
EP3571183B1
(en)
|
2017-01-20 |
2024-03-06 |
The Regents of the University of California |
3-(phenyl)-2-(aminomethyl)-1-phenyl-2-propen-1-one derivatives as inhibitors of the n-terminal domain of the androgen receptor for treating prostate cancer
|
|
US10231947B2
(en)
|
2017-01-23 |
2019-03-19 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Isochroman compounds and methods of use thereof
|
|
US10238655B2
(en)
|
2017-01-23 |
2019-03-26 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Dihydroindene and tetrahydronaphthalene compounds
|
|
US10238626B2
(en)
|
2017-01-23 |
2019-03-26 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Therapeutic compounds
|
|
WO2018140504A1
(en)
|
2017-01-24 |
2018-08-02 |
Patel Manoj K |
Compositions and methods for blocking sodium channels
|
|
US10294264B2
(en)
|
2017-04-21 |
2019-05-21 |
Warsaw Orthopedic, Inc. |
Oxysterol-therapeutic agent derivative for bone healing
|
|
CA3063174A1
(en)
|
2017-05-12 |
2018-11-15 |
Innovus Pharmaceuticals, Inc. |
Therapeutic methods and compositions
|
|
US10434106B2
(en)
|
2017-05-19 |
2019-10-08 |
Warsaw Orthopedic, Inc. |
Oxysterol-statin compounds for bone growth
|
|
JP2020520949A
(ja)
|
2017-05-22 |
2020-07-16 |
ユニバーシティ オブ ヴァージニア パテント ファウンデーションＵｎｉｖｅｒｓｉｔｙ Ｏｆ Ｖｅｒｇｉｎｉａ Ｐａｔｅｎｔ Ｆｏｕｎｄａｔｉｏｎ |
組成物、並びにミトコンドリア脱共役剤を調製及び使用する方法
|
|
AR112027A1
(es)
|
2017-06-15 |
2019-09-11 |
Biocryst Pharm Inc |
Inhibidores de alk 2 quinasa que contienen imidazol
|
|
US20180371526A1
(en)
|
2017-06-23 |
2018-12-27 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Compositions and methods for detecting viral nucleic acids
|
|
US10934300B2
(en)
|
2017-06-23 |
2021-03-02 |
San Diego State University (Sdsu) Foundation |
Atropisomerism for enhanced kinase inhibitor selectivity
|
|
EP3676255B1
(en)
|
2017-08-29 |
2025-04-16 |
Rutgers, The State University University Of New Jersey |
Therapeutic indazoles
|
|
TW201932100A
(zh)
|
2017-08-30 |
2019-08-16 |
美國亞利桑那州立大學亞利桑那州評議委員會 |
Ｒｎａ奈米結構及製備與使用ｒｎａ奈米結構之方法
|
|
CA3076233A1
(en)
|
2017-10-06 |
2019-04-11 |
Blue Therapeutics, Inc. |
Methods of treating acute or chronic pain
|
|
AU2018351714A1
(en)
|
2017-10-16 |
2020-04-30 |
Aragon Pharmaceuticals, Inc. |
Anti-androgens for the treatment of non-metastatic castration-resistant prostate cancer
|
|
JP2021503481A
(ja)
|
2017-11-17 |
2021-02-12 |
サイトジェル ファーマ リミテッド ライアビリティ カンパニー |
μオピオイド受容体のポリマーアゴニスト
|
|
SG11202004384YA
(en)
|
2017-11-17 |
2020-06-29 |
Univ Illinois |
Cancer therapy by degrading dual mek signaling
|
|
AU2018375087B2
(en)
|
2017-11-30 |
2023-10-05 |
Cytogel Pharma, Llc |
Novel analgesic pharmaceutical formulations and uses thereof
|
|
US11242533B2
(en)
|
2018-01-10 |
2022-02-08 |
Arizona Board Of Regents On Behalf Of Arizona State University |
RNA-nanostructured double robots and methods of use thereof
|
|
US10738093B2
(en)
|
2018-01-25 |
2020-08-11 |
The Hong Kong University Of Science And Technology |
Discovery of cationic nonribosomal peptides as Gram-negative antibiotics through global genome mining
|
|
WO2019160873A1
(en)
|
2018-02-13 |
2019-08-22 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: o-alkyl-deuterated pyronins
|
|
TWI884912B
(zh)
|
2018-02-15 |
2025-06-01 |
生華生物科技股份有限公司 |
喹啉酮類似物及其鹽、組合物及其使用方法
|
|
WO2019168921A1
(en)
|
2018-02-27 |
2019-09-06 |
University Of Virginia Patent Foundation |
Plectin-targeted liposomes/parp inhibitor in the treatment of cancer
|
|
WO2019173507A1
(en)
|
2018-03-06 |
2019-09-12 |
Rutgers, The State University Of New Jersey |
Antibacterial agents : arylalkylcarboxamido phloroglucinols
|
|
TWI873092B
(zh)
|
2018-04-06 |
2025-02-21 |
美商百歐克斯製藥公司 |
取代的苯并呋喃、苯并吡咯、苯并噻吩及結構相關的補體抑制劑
|
|
CN112262141A
(zh)
|
2018-04-20 |
2021-01-22 |
弗吉尼亚理工大学知识产权有限公司 |
可用作线粒体解偶联剂的咪唑吡啶
|
|
US12344845B2
(en)
|
2018-04-27 |
2025-07-01 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Highly knotted molecular topologies from single-stranded nucleic acids
|
|
ES3034597T3
(en)
|
2018-04-27 |
2025-08-20 |
Univ Iowa Res Found |
Compositions for chelating metals at low temperatures
|
|
EP3810641A4
(en)
|
2018-06-19 |
2022-07-13 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
ONCOLYTIC VIRUS OR ANTIGEN PRESENT CELL MEDIATED CANCER THERAPY USING TYPE I INTERFERON AND CD40 LIGAND
|
|
US10912822B2
(en)
|
2018-06-26 |
2021-02-09 |
Marine Essence Biosciences Corporation of USA |
Biomaterial devices and topical compositions for guided tissue regeneration
|
|
US10758594B2
(en)
|
2018-06-26 |
2020-09-01 |
Marine Essence Biosciences Corporation of USA |
Biomaterial devices and topical compositions for treatment of skin abnormalities
|
|
BR112021000395A2
(pt)
|
2018-07-11 |
2021-04-06 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Compostos imunomoduladores diméricos contra mecanismos baseados em cereblon
|
|
US10898460B1
(en)
|
2018-07-20 |
2021-01-26 |
University Of South Florida |
Leishmania inhibitors
|
|
US11987568B2
(en)
|
2018-08-03 |
2024-05-21 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Allosteric inhibitor of WEE1 kinase
|
|
EP3833342A4
(en)
|
2018-08-09 |
2022-07-13 |
The Board of Trustees of the University of Illinois |
IMIDAZOTETRAZINE COMPOUNDS
|
|
US11332499B2
(en)
|
2018-08-16 |
2022-05-17 |
Regents Of The University Of Minnesota |
Cyclic peptides and methods of use thereof
|
|
WO2020037116A1
(en)
|
2018-08-17 |
2020-02-20 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Small molecule pyrin-domain targeted nlrp3 inflammasome inhibitors
|
|
JP6933394B2
(ja)
*
|
2018-09-06 |
2021-09-08 |
マリン エッセンス バイオサイエンシズ コーポレーション オブ ユーエスエーＭａｒｉｎｅ Ｅｓｓｅｎｃｅ Ｂｉｏｓｃｉｅｎｃｅｓ Ｃｏｒｐｏｒａｔｉｏｎ ｏｆ ＵＳＡ |
組織再生誘導のためのバイオマテリアルデバイスおよび局所用組成物
|
|
US12600710B2
(en)
|
2018-10-18 |
2026-04-14 |
Lee Moffitt Cancer Center and Research Institute, Inc. |
Beta-catenin and b-cell lymphoma 9 (BCL9) inhibitors
|
|
WO2020081918A2
(en)
|
2018-10-18 |
2020-04-23 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Βeta-catenin and b-cell lymphoma 9 (bcl9) inhibitors
|
|
EP3877439B1
(en)
|
2018-11-07 |
2026-03-11 |
Regents of the University of Minnesota |
Analgesic and anti-addictive compositions for treatment of chronic pain and opioid addiction
|
|
CN113302206A
(zh)
|
2018-11-26 |
2021-08-24 |
戴纳立制药公司 |
治疗脂质代谢失调的方法
|
|
US12215106B2
(en)
|
2018-11-27 |
2025-02-04 |
Rutgers, The State University Of New Jersey |
Pharmaceutical compounds and therapeutic methods
|
|
US12269899B2
(en)
|
2018-12-07 |
2025-04-08 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Peptidomimetic inhibitors of β-catenin/Tcf protein-protein interaction
|
|
US12414983B2
(en)
|
2019-01-14 |
2025-09-16 |
Regents Of The University Of Minnesota |
CD200AR ligands for cancer immunotherapy
|
|
US10889601B2
(en)
|
2019-02-11 |
2021-01-12 |
University Of Iowa Research Foundation |
Separations using boron containing hydrocarbon sponges
|
|
WO2020225779A1
(en)
|
2019-05-09 |
2020-11-12 |
Istituto Pasteur Italia - Fondazione Cenci Bolognetti |
Rig-i agonists for cancer treatment and immunotherapy
|
|
US20220411398A1
(en)
|
2019-06-24 |
2022-12-29 |
University Of Iowa Research Foundation |
Jnk inhibitors as anticancer agents
|
|
US11840703B2
(en)
|
2019-07-01 |
2023-12-12 |
Matrexa LLC |
Recombinant versican isoforms and related compositions and methods
|
|
TN2022000028A1
(en)
|
2019-08-06 |
2023-10-09 |
Biocryst Pharm Inc |
Process-scale synthesis of a plasma kallikrein inhibitor
|
|
PY2062546A
(es)
|
2019-10-09 |
2021-09-13 |
Biocryst Pharm Inc |
Inhibidores del factor d del complemento para administración oral
|
|
US12234578B2
(en)
|
2020-01-29 |
2025-02-25 |
Wisconsin Alumni Research Foundation |
Tannin composite fibers
|
|
US12552806B2
(en)
|
2020-03-20 |
2026-02-17 |
University Of Southern California |
Androgen receptor regulation by small molecule enantiomers
|
|
AR121715A1
(es)
|
2020-04-03 |
2022-06-29 |
Biocryst Pharm Inc |
Pirrolopirimidinaminas como inhibidores del sistema del complemento
|
|
EP4136095A1
(en)
|
2020-04-17 |
2023-02-22 |
Regents of the University of Minnesota |
Sars-cov-2 spike receptor binding domain and compositions and methods thereof
|
|
US12318469B2
(en)
|
2020-06-30 |
2025-06-03 |
L'oréal |
Cosmetic compositions capable of forming a multilayer structure after application to a keratinous material containing a combination of silicone resins
|
|
US11529335B2
(en)
|
2020-07-31 |
2022-12-20 |
University Of Iowa Research Foundation |
Compositions and methods for treating cancer
|
|
WO2022155332A1
(en)
|
2021-01-13 |
2022-07-21 |
Blue Therapeutics, Inc. |
Methods of treating irritable bowel syndrome
|
|
KR20230148180A
(ko)
|
2021-02-22 |
2023-10-24 |
리전츠 오브 더 유니버스티 오브 미네소타 |
면역조절제 및 면역조절제 컨쥬게이트
|
|
US12303564B2
(en)
|
2021-03-19 |
2025-05-20 |
Wisconsin Alumni Research Foundation |
Composite chitosan-tannin-active agent compositions and methods of making and using same
|
|
JP2022151457A
(ja)
*
|
2021-03-26 |
2022-10-07 |
株式会社ピカソ美化学研究所 |
皮膚用組成物
|
|
CA3217096A1
(en)
|
2021-05-04 |
2022-11-10 |
Ingrid Gunda Georg |
Contraceptive compounds and methods
|
|
US12447135B2
(en)
|
2021-10-11 |
2025-10-21 |
University Of South Florida |
Fenchol as a stimulator of free fatty acid receptor and other uses thereof
|
|
US20250025447A1
(en)
|
2021-11-03 |
2025-01-23 |
Regents Of The University Of Minnesota |
Toll-like receptor agonists and antagonists and uses thereof
|
|
WO2023091689A1
(en)
|
2021-11-19 |
2023-05-25 |
University Of Iowa Research Foundation |
Combined use of mcr1-directed radiotherapy and immune checkpoint inhibition in the treatment of melanoma
|
|
WO2024006977A1
(en)
|
2022-07-01 |
2024-01-04 |
University Of Southern California |
Analgesic delta opioid receptor bitopic ligands
|
|
WO2024009283A1
(en)
|
2022-07-07 |
2024-01-11 |
University Of Southern California |
At2 antagonists for non-addictive pain relief
|
|
CA3261160A1
(en)
|
2022-07-08 |
2024-01-11 |
Actio Biosciences, Inc. |
COMPOUNDS AND THERAPEUTIC METHODS
|
|
WO2024054678A2
(en)
|
2022-09-09 |
2024-03-14 |
Regents Of The University Of Minnesota |
Antibodies against fentanyl and analogs and methods of use thereof
|
|
WO2024102342A1
(en)
|
2022-11-10 |
2024-05-16 |
University Of Iowa Research Foundation |
Combination of a glutathione synthesis inhibitor such as buthionine sulphoximine and an immune checkpoint inhibitor, preferably pembrolizumab, to treat cancer, preferably drug-resistant melanoma
|
|
WO2024112932A1
(en)
|
2022-11-23 |
2024-05-30 |
Regents Of The University Of Minnesota |
Immunomodulators and immunomodulator conjugates
|
|
AU2023390336A1
(en)
|
2022-12-07 |
2025-06-19 |
Nemagen Discoveries, Inc. |
Carbonic anhydrase enzyme inhibitors and methods of use thereof
|
|
WO2024197165A1
(en)
|
2023-03-21 |
2024-09-26 |
University Of Iowa Research Foundation |
Broad spectrum antifungal keto-alkyl-pyridinium compounds
|
|
WO2024206284A2
(en)
|
2023-03-27 |
2024-10-03 |
Rutgers, The State University Of New Jersey |
Therapeutic compounds
|
|
WO2024226603A1
(en)
|
2023-04-24 |
2024-10-31 |
Regents Of The University Of Minnesota |
Therapeutic compounds
|
|
US20250186630A1
(en)
|
2023-12-12 |
2025-06-12 |
Viewpoint Molecular Targeting, Inc. |
Fibroblast activation protein targeting peptides
|
|
WO2025259601A1
(en)
|
2024-06-10 |
2025-12-18 |
Nemagen Discoveries, Inc. |
Carbonic anhydrase enzyme inhibitors and methods of use thereof
|
|
WO2026060616A1
(en)
|
2024-09-20 |
2026-03-26 |
Fulcrum Therapeutics, Inc. |
Phenothiazine and phenoxazine calmodulin inhibitors and methods of use thereof
|
|
WO2026076223A1
(en)
|
2024-10-03 |
2026-04-09 |
Regents Of The University Of Minnesota |
Therapeutic compounds and methods of use thereof
|